You are here

US drug benefit manager cuts coverage for 35 products in exclusion expansion

The excluded drugs list includes those that have had "hyperinflationary" price increases

While CVS used to review prices once a year, it now has a team of people that check at least weekly for unexpected spikes, Mr Brennan said.

New York

CVS Health Corp will add 35 products to its lists of excluded drugs in 2017 and no longer cover some treatments for cancer and diabetes, in an aggressive move to favour lower-priced treatments and target what the company called "hyperinflation" of some other products.